Regulatory News In Brief

NAD refers Generix Labs’ BiphedAdrene ads to FTC; ABCO Labs cited for misbranded and unapproved new drugs; FDA warns RockStar on beverage additives; more Regulatory News In Brief.

More from United States

More from North America